The study used data from 539,400 prescriptions that included at least one multiple sclerosis drug. Real-world prescription data show that throughout the COVID-19 pandemic, the use of MS medications and co-prescribed antidepressants was stable. These insights from real-world data demonstrate the value of evidence-based insights for managing patient care.
Orschiedt, J., Jacyshyn-Owen, E., Kahn, M., Jansen, S., Joschko, N., Eberl, M., … Ziemssen, T. (2023). The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany. Biomedicine & Pharmacotherapy, 158(114129), 114129.
